Scandinavian Real Heart AB Logo

Scandinavian Real Heart AB

Develops a total artificial heart for patients awaiting a heart transplant.

HEART | ST

Overview

Corporate Details

ISIN(s):
SE0006256798 (+3 more)
LEI:
549300HFGZRJQVLZI163
Country:
Sweden
Address:
Kopparbergsvägen 6, 722 13 Västerås

Description

Scandinavian Real Heart AB is a medical technology company developing a total artificial heart (TAH) for patients with life-threatening, end-stage heart failure. Its main product, the Realheart® TAH, is designed to completely replace a diseased heart, primarily serving as a transitional solution for patients awaiting a heart transplant. A key innovation of the device is its ability to mimic the natural heart's function by generating a pulsatile blood flow, which is intended to more closely replicate the body's physiological circulation. The company's objective is to save lives and improve the quality of life for individuals with advanced heart conditions. The device has received a Humanitarian Use Device (HUD) designation from the U.S. Food and Drug Administration (FDA).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Scandinavian Real Heart AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Scandinavian Real Heart AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Scandinavian Real Heart AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-17 Magnus Öhman Other Buy 4,500 51,300.00 SEK
2025-01-17 Magnus Öhman Other Buy 500 5,750.00 SEK
2025-01-16 Magnus Öhman Other Buy 500 5,650.00 SEK
2025-01-16 Magnus Öhman Other Buy 500 5,550.00 SEK
2025-01-16 Magnus Öhman Other Buy 500 5,515.60 SEK
2025-01-16 Magnus Öhman Other Buy 200 2,180.00 SEK
2024-11-19 Azad Najar Other Other 409,000 N/A

Peer Companies

Biocorp Logo
Designs, develops, and manufactures medical devices and drug delivery systems.
France
ALCOR
BIODYNE CO., LTD. Logo
Developer of medical devices and reagents for cancer diagnosis solutions.
South Korea
314930
Biohit Oyj Logo
Develops diagnostic products for early disease detection, focusing on gastroenterology.
Finland
BIOBV
BioNote, Inc. Logo
Develops and manufactures in-vitro diagnostic products for the animal health industry.
South Korea
377740
Researches and develops hyaluronic acid-based biomaterials for beauty and healthcare.
South Korea
099430
Bioretec Oy Logo
Develops and manufactures bioresorbable orthopedic implants for adults and children.
Finland
BRETEC
Bioventus Inc. Logo
A medical device company developing innovations for active healing in orthopedics.
United States of America
BVS
Bluejay Diagnostics, Inc. Logo
Develops a near-patient platform for rapid, cost-effective disease diagnostics.
United States of America
BJDX
Bonesupport Holding Logo
Develops and commercializes injectable bio-ceramic bone graft substitutes.
Sweden
BONEX
BOSTON SCIENTIFIC CORP Logo
Develops and manufactures high-performance medical devices for interventional procedures.
United States of America
BSX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.